Stealth BioTherapeutics Corp - ADR

NASDAQ:MITO   3:28:00 PM EDT
0.89
+0.02 (+2.28%)
Products, Regulatory

Stealth BioTherapeutics Provides Update On Clinical Stage Rare Disease Programs

Published: 12/13/2021 13:52 GMT
Stealth BioTherapeutics Corp - ADR (MITO) - Stealth Biotherapeutics Provides Update on Clinical Stage Rare Disease Programs.
Stealth Biotherapeutics Corp - Nupower Phase 3 Clinical Trial Initiation Activities Underway.
Stealth Biotherapeutics Corp - New Data Showing Improved Dystrophin Levels in Animal Models Builds Further Confidence in Dmd Development Program.
Stealth Biotherapeutics Corp - Additional Interactions Planned With Division of Cardiology and Nephrology (dcn) Following Constructive Type a Meeting.